Bio Usawa Inc. funding
Bio Usawa Inc., a biotechnology company based in San Francisco, CA (founded 2023), filed a Form D with the SEC on December 17, 2025 and reported $1.7M raised. It filed 3 new offerings in this period, totaling $2.6M.
Amount raised$1.7M
Offering size$1.7M
Filed with the SECDecember 17, 2025
First saleFebruary 21, 2024
IndustryBiotechnology
SecuritiesEquity
LocationSan Francisco, CA
Founded2023
Entity typeCorporation
Investors so far25
Minimum investment$5K
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Dec 17
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| December 17, 2025 | $1.7M | $1.7M | Equity |
| December 17, 2025 | $450K | $450K | Equity |
| December 17, 2025 | $404K | $404K | Equity |
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology